CorWave Appoints Jim Schuermann as an Independent Director.
CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device.
CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device.
CorWave’s next-generation LVAD receives funding.
Corwave Announces Issuance of US Patent Covering Its Implantable Left Ventricular Assist Device Leveraging the Wave Membrane Technology.
CorWave scales up increasing its R&D capabilities and opening a pilot production unit at its new Clichy site.
CorWave is pegged as a potential billion-euro company as part of “Future Unicorn” competition.
CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support.
CorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region.
CorWave Raises $17.1 Million in Series B Financing.
CorWave Awarded at the Worldwide Innovation Challenge.
CorWave Presents Promising Early Results for Innovative Wave Membrane Blood Pump.